Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study

被引:1
作者
Stocker, Melanie [1 ]
Zimmermann, Simona E. [1 ]
Laager, Rahel [1 ]
Gregoriano, Claudia [1 ]
Mueller, Beat [1 ,2 ,3 ]
Schuetz, Philipp [1 ,2 ,3 ]
Kutz, Alexander [1 ,4 ,5 ,6 ]
机构
[1] Kantonsspital Aarau, Med Univ Dept, Div Gen Internal & Emergency Med, Aarau, Switzerland
[2] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland
[3] Univ Basel, Fac Med, Basel, Switzerland
[4] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Med Univ, Kantonsspital Aarau, Dept Med, Tellstr 25, CH-5001 Aarau, Switzerland
关键词
Acromegaly; NFPA; Pituitary surgery; Cardiovascular outcomes; Mortality; TREATMENT PATTERNS; MORTALITY; COMORBIDITIES; MANAGEMENT; HYPOPITUITARISM; POPULATION; DIAGNOSIS; DISEASE; ADULTS;
D O I
10.1007/s11102-024-01405-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeGiven the increased cardio-metabolic risk in patients with acromegaly, this study compared cardiovascular outcomes, mortality, and in-hospital outcomes between patients with acromegaly and non-functioning pituitary adenoma (NFPA) following pituitary surgery.MethodsThis was a nationwide cohort study using data from hospitalized patients with acromegaly or NFPA undergoing pituitary surgery in Switzerland between January 2012 and December 2021. Using 1:3 propensity score matching, eligible acromegaly patients were paired with NFPA patients who underwent pituitary surgery, respectively. The primary outcome comprised a composite of cardiovascular events (myocardial infarction, cardiac arrest, ischemic stroke, hospitalization for heart failure, unstable angina pectoris, cardiac arrhythmias, intracranial hemorrhage, hospitalization for hypertensive crisis) and all-cause mortality. Secondary outcomes included individual components of the primary outcome, surgical re-operation, and various hospital-associated outcomes.ResultsAmong 231 propensity score-matched patients with acromegaly and 491 with NFPA, the incidence rate of the primary outcome was 8.18 versus 12.73 per 1,000 person-years (hazard ratio [HR], 0.64; [95% confidence interval [CI], 0.31-1.32]). Mortality rates were numerically lower in acromegaly patients (2.43 vs. 7.05 deaths per 1,000 person-years; HR, 0.34; [95% CI, 0.10-1.17]). Individual components of the primary outcome and in-hospital outcomes showed no significant differences between the groups.ConclusionThis cohort study did not find an increased risk of cardiovascular outcomes and mortality in patients with acromegaly undergoing pituitary surgery compared to surgically treated NFPA patients. These findings suggest that there is no legacy effect regarding higher cardio-metabolic risk in individuals with acromegaly once they receive surgical treatment.
引用
收藏
页码:518 / 526
页数:9
相关论文
共 33 条
  • [1] Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
    Berg, Christian
    Petersenn, Stephan
    Lahner, Harald
    Herrmann, Burkhard L.
    Buchfelder, Michael
    Droste, Michael
    Stalla, Guenter K.
    Strasburger, Christian J.
    Roggenbuck, Ulla
    Lehmann, Nils
    Moebus, Susanne
    Joeckel, Karl-Heinz
    Moehlenkamp, Stephan
    Erbel, Raimund
    Saller, Bernhard
    Mann, Klaus
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08) : 3648 - 3656
  • [2] Bonadonna S., 2005, J ENDOCRINOL INVEST, V28
  • [3] Management of clinically non-functioning pituitary adenoma
    Chanson, Philippe
    Raverot, Gerald
    Castinetti, Frederic
    Cortet-Rudelli, Christine
    Galland, Francoise
    Salenave, Sylvie
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 239 - 247
  • [4] Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications
    Chen, Ching-Jen
    Ironside, Natasha
    Pomeraniec, I. Jonathan
    Chivukula, Srinivas
    Buell, Thomas J.
    Ding, Dale
    Taylor, Davis G.
    Dallapiazza, Robert F.
    Lee, Cheng-Chia
    Bergsneider, Marvin
    [J]. ACTA NEUROCHIRURGICA, 2017, 159 (11) : 2193 - 2207
  • [5] Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study
    Colao, Annamaria
    Pivonello, Rosario
    Grasso, Ludovica Francesca Stella
    Auriemma, Renata Simona
    Galdiero, Mariano
    Savastano, Silvia
    Lombardi, Gaetano
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (05) : 713 - 721
  • [6] Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
    Dal, Jakob
    Feldt-Rasmussen, Ulla
    Andersen, Marianne
    Kristensen, Lars O.
    Laurberg, Peter
    Pedersen, Lars
    Dekkers, Olaf M.
    Sorensen, Henrik Toft
    Jorgensen, Jens Otto L.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (03) : 181 - 190
  • [7] Mortality in acromegaly: A meta analysis
    Dekkers, O. M.
    Biermasz, N. R.
    Pereira, A. M.
    Romijn, J. A.
    Vandenbroucke, J. P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) : 61 - 67
  • [8] EDI E.D.d.I., 2022, SYSTEMATISCHES VERZE
  • [9] Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study
    Esposito, Daniela
    Ragnarsson, Oskar
    Granfeldt, Daniel
    Marlow, Tom
    Johannsson, Gudmundur
    Olsson, Daniel S.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (05) : 459 - 469
  • [10] Acromegaly: pathogenesis, diagnosis, and management
    Fleseriu, Maria
    Langlois, Fabienne
    Lim, Dawn Shao Ting
    Varlamov, Elena V.
    Melmed, Shlomo
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (11) : 804 - 826